A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer

A. Mercalli, V. Sordi, R. Formicola, M. Dandrea, S. Beghelli, A. Scarpa, V. Di Carlo, M. Reni, L. Piemonti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences